MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$5,486K
Net Income
-$32,097K
Net Profit Margin
-585.07%
EPS
-$1.02
Unit: Thousand (K) dollars
Revenue Breakdown
License
Product
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
5,486
1,901
-7,162*
12,500
Cost of sales
280
1,076
105*
-
Selling, general and administrative
39,378
44,960
30,864*
27,596
Research and development
0
0
-608*
3,791
Total operating expenses
39,658
46,036
30,360*
31,387
Loss from operations
-34,172
-44,135
-37,522*
-18,887
Other (expense) income
-13
3
-520*
-14
Interest income
2,270
2,644
3,086*
2,201
Total other income, net
2,257
2,647
2,565*
2,187
Net loss before income taxes
-31,915
-
-34,957*
-16,700
Income tax expense
3
-
-248*
0
Net loss
-31,918
-41,488
-34,709*
-16,700
Unrealized gain on marketable securities
-179
-692
-110*
189
Comprehensive loss
-32,097
-42,180
-34,819
-16,511
Basic EPS
-1.02
-1.32
-1.168
-0.59
Diluted EPS
-1.02
-1.32
-1.168
-0.59
Basic Average Shares
31,374,311
31,352,702
29,819,902
28,540,519
Diluted Average Shares
31,374,311
31,352,702
29,819,902
28,540,519
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$32,097K
(-114.02%↓ Y/Y)
Net loss
-$31,918K
(-114.04%↓ Y/Y)
Unrealized gain on
marketable securities
-$179K
(-110.59%↓ Y/Y)
Interest income
$2,270K
(1.07%↑ Y/Y)
Net loss before
income taxes
-$31,915K
(-121.45%↓ Y/Y)
Income tax expense
$3K
(-99.40%↓ Y/Y)
Total other income,
net
$2,257K
(-7.69%↓ Y/Y)
License
$3,750K
Product
$1,736K
Other (expense)
income
-$13K
(-106.53%↓ Y/Y)
Loss from operations
-$34,172K
(-102.72%↓ Y/Y)
Total revenue
$5,486K
(9.72%↑ Y/Y)
Total operating
expenses
$39,658K
(81.44%↑ Y/Y)
Selling, general and
administrative
$39,378K
(207.74%↑ Y/Y)
Cost of sales
$280K
Buy us a coffee
LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. (LENZ)